neurofibrosarcoma/vòmit

L'enllaç es desa al porta-retalls

Trieu el tipus d'ordenació

13 resultats

Intracranial malignant peripheral nerve sheath tumor variant: an unusual neurovascular phenotype sarcoma case invading through the petrous bone.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND Intracranial malignant peripheral nerve sheath tumor (MPNST) is exceedingly rare. Previously reported cases of intracranial MPNST have been associated with development within a prominent cranial nerve. METHODS This is the first report of an MPNST with both nerve sheath and vascular

Malignant peripheral nerve sheath tumor of the pancreas-A case report.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Nerve sheath tumors are tumors arising from nerve sheaths or which show nerve sheath differentiation. They are divided as benign and malignant. They are associated with Von Recklinghausen syndrome. Characterised by café-au-lait spots, lisch nodules, acoustic neuromas,

Malignant peripheral nerve sheath tumor of the occipital region: case report.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

OBJECTIVE A rare case of a malignant peripheral nerve sheath tumor of the occipital region is presented. The role of postoperative radiotherapy in such cases is reviewed. METHODS A 36-year-old man presented with a small spongy swelling in the posterior aspect of the cranium since childhood. The

A distal ileum malignant peripheral nerve sheath tumor causing intussusception in a patient in China: a case report.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

BACKGROUND Malignant peripheral nerve sheath tumors (MPNSTs) arise from a peripheral nerve or display nerve sheath differentiation. Most MPNSTs typically originate on the trunk, extremities, head, neck, and paravertebral regions. Gastrointestinal MPNSTs are rare entities with only 10 cases reported

ADVL1522: A phase 2 study of lorvotuzumab mertansine (IMGN901) in children with relapsed or refractory wilms tumor, rhabdomyosarcoma, neuroblastoma, pleuropulmonary blastoma, malignant peripheral nerve sheath tumor, or synovial sarcoma-A Children's Oncology Group study

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Background: Lorvotuzumab mertansine (IMGN901) is an antibody-drug conjugate linking an antimitotic agent (DM1) to an anti-CD56 antibody (lorvotuzumab). Preclinical efficacy has been noted in Wilms tumor, rhabdomyosarcoma, and

Catecholamine-secreting malignant schwannoma in a patient with multiple intracranial aneurysms. Case report.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

A case is reported of malignant schwannomatosis (malignant transformation of von Recklinghausen's disease) with catecholamine production in a patient with multiple intracranial aneurysms. The patient had a history of episodic hypertension and elevated levels of catecholamines in the serum and

Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

One hundred and forty adult patients with advanced sarcomas (125 soft tissue and 15 bone) were treated with a combination chemotherapy regimen consisting of cyclophosphamide, vincristine, Adriamycin, and DTIC (CYVADIC). There were 21 (15%) complete and 45 (32%) partial responders, with an overall

Possible contribution of aprepitant to ifosfamide-induced neurotoxicity.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

OBJECTIVE A case of ifosfamide-induced neurotoxicity after the addition of aprepitant to an antiemetic regimen is reported. CONCLUSIONS A 24-year-old white man diagnosed with a malignant peripheral nerve sheath tumor initially in the late 1990s was admitted to the hospital for treatment of a

Five-Year-Old Boy With Behavioral Changes and Papilledema.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

A 5-year-old boy had initial symptoms of behavioral changes, nausea, vomiting, headache, weight loss, and progressive vision failure. Brain MRI revealed abnormal signal intensity in both optic nerves, the optic chiasm, the right medial temporal lobe, and tissues surrounding the right supraclinoid

Phase II trial of ifosfamide in children with malignant solid tumors.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Ifosfamide was given to 61 patients with malignant solid tumors diagnosed before the age of 21 years. In this phase II study, all patients received 1.6 g/m2/day X 5 iv over 15 minutes followed by mesna at a dose of 400 mg/m2 iv at 15 minutes and 4 and 6 hours after ifosfamide. Responses were

Hypersensitivity pneumonitis associated with the use of trofosfamide.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Trofosfamide (Ixoten; Baxter Oncology, Germany) is an alkylating agent that, as with other oxazaphosphorine derivatives, has to be activated by hepatic cytochrome P450 oxidases. The bioavailability is nearly 100% after oral application, and the main metabolites are 4-hydroxytrofosfamide, and

[Multiple malignant intracerebral schwannomas in von Recklinghausen's disease--report of a case].

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Intracerebral schwannoma is very rare, and only nine cases of solitary intracerebral schwannoma have been reported since the first description by Gibson et al, in 1966. This report is the first case of multiple intracerebral schwannomas in Japan. Intracranial extracerebral schwannomas in von

N-(phosphonacetyl)-L-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group.

Només els usuaris registrats poden traduir articles

Inicieu sessió / registreu-vos

Thirty-six patients with measurable or evaluable advanced soft tissue sarcoma were entered in a phase II trial with PALA. Among the 27 evaluable patients, 15 were men, the median age was 55 yr (16-69) and the median performance status (Karnofsky) was 80 (50-100). Most patients had leiomyosarcoma

Uneix-te a la nostra
pàgina de Facebook

Herbal & Natural Medicine

La base de dades d’herbes medicinals més completa avalada per la ciència

Funciona en 55 idiomes
Cures a base d'herbes recolzades per la ciència
Reconeixement d’herbes per imatge
Mapa GPS interactiu: etiqueta les herbes a la ubicació (properament)
Llegiu publicacions científiques relacionades amb la vostra cerca
Cerqueu herbes medicinals pels seus efectes
Organitzeu els vostres interessos i estigueu al dia de les novetats, els assajos clínics i les patents

Escriviu un símptoma o una malaltia i llegiu sobre herbes que us poden ajudar, escriviu una herba i vegeu malalties i símptomes contra els quals s’utilitza.
* Tota la informació es basa en investigacions científiques publicades